AUDIT
审计
基本信息
- 批准号:7515876
- 负责人:
- 金额:$ 10.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-14 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdverse eventAffectAppendixCategoriesClinical TrialsDataData QualityDatabasesDisease OutcomeDoseElectronicsEligibility DeterminationEnsureEvaluationGoalsIndividualInformed ConsentMonitorNorth Central Cancer Treatment GroupProcessProductivityProtocols documentationQuality ControlReportingResolutionSeveritiesSiteSpecialistSystemToxic effectTraining and EducationWritingdayfollow-uphuman subjectresponseuser-friendly
项目摘要
2.8.1.6 Internal Audits
The NCCTG Quality Control Unit conducts rigorous internal audits to verify internal compliance with SOPs,
proper use of automated systems, and internal consistency. The goal of these audits is to further assure the
quality of the study data, to ensure the delivery of accurate, timely and reliable trial results, and to provide
educational support to the staff. Concurrently with these audits, the electronic applications are reviewed to
ensure that systems are being used correctly, ensure the systems are user friendly and functioning properly,
and identify any improvements necessary to increase the overall efficiency and productivity of the unit.
The audits are conducted at least annually and last one to two days. Studies are selected randomly with at
least 2-5 cases being chosen for each Quality Control Specialist. An audit check list is used to ensure a
comprehensive review of charts. Eligibility, objective response, dosing, adverse event reporting, and
timeliness of editing are reviewed. The second objective of the audit, ensuring systems are functioning and
being used correctly, is accomplished by verifying that the proper edits were identified, that case evaluation
reviews were triggered when appropriate, and that the materials tracking system was correctly implemented.
Upon completion of the audit, each Quality Control Specialist receives a written audit report and is asked to
address and clarify any items of concern within thirty days of receipt. The quality control specialist supervisor
reviews all responses for acceptability and follow-up with the quality control specialist on training and education
needs.
2.8.1.7 NCCTG External Audit
All NCCTG memberships are audited at least once every 3 years to further ensure the delivery of accurate and
reliable clinical trials data and results, to verify the accuracy of submitted data, to monitor compliance to the
study protocol, to verify adherence to regulatory requirements for the protection of human subjects and the
handling of investigational agents, and to provide educational support to the NCCTG memberships. The
results of these audits are reviewed by the NCCTG Audit Committee who oversees the audit process for
NCCTG and reports directly to the NCCTG Executive Committee. The results of individual chart review are
summarized by category (informed consent, eligibility, treatment, disease outcome, toxicity, and general data
quality) and severity of discrepancy (lesser or major). The percent of major deficiencies has remained low with
the median percent of major deficiencies below 5% (2001=3%, 2002=4%, 2003=3%, 2004=1%, 2005=2%).
When deficiencies are identified that potentially affect submitted data, a memo is sent to both the primary CRA
at the site and the quality control specialist communicating the data discrepancy. The quality control specialist
is then responsible for tracking the query until resolution in the database. An audit report is included as
Appendix XI.
2.8.1.6 内部审计
NCCTG 质量控制部门进行严格的内部审核,以验证内部是否遵守 SOP、
正确使用自动化系统以及内部一致性。这些审计的目的是进一步确保
研究数据的质量,确保提供准确、及时、可靠的试验结果,并提供
对员工的教育支持。在进行这些审核的同时,还会对电子申请进行审核,以确保
确保系统被正确使用,确保系统用户友好且正常运行,
并确定提高单位整体效率和生产力所需的任何改进。
审核至少每年进行一次,持续一到两天。研究是随机选择的
为每位质量控制专家至少选择 2-5 个案例。审核检查表用于确保
图表的全面审查。资格、客观反应、剂量、不良事件报告以及
审查编辑的及时性。审计的第二个目标是确保系统正常运行
正确使用是通过验证是否识别了正确的编辑来完成的,案例评估
在适当的时候触发审查,并且材料跟踪系统得到正确实施。
审核完成后,每位质量控制专家都会收到一份书面审核报告,并被要求
在收到后三十天内解决并澄清任何关注的事项。质量控制专家主管
与培训和教育质量控制专家一起审查所有答复的可接受性和后续行动
需要。
2.8.1.7 NCCTG 外部审计
所有 NCCTG 会员至少每 3 年接受一次审核,以进一步确保提供准确和可靠的信息
可靠的临床试验数据和结果,验证提交数据的准确性,监控对临床试验的遵守情况
研究方案,以验证是否遵守保护人类受试者的监管要求和
处理调查代理人,并向 NCCTG 会员提供教育支持。这
这些审计结果由 NCCTG 审计委员会审查,该委员会负责监督审计过程
NCCTG 并直接向 NCCTG 执行委员会报告。个别图表审核的结果是
按类别总结(知情同意、资格、治疗、疾病结果、毒性和一般数据
质量)和差异的严重程度(较小或较大)。重大缺陷的比例仍然较低
主要缺陷的中位数百分比低于5%(2001年=3%,2002年=4%,2003年=3%,2004年=1%,2005年=2%)。
当发现可能影响提交数据的缺陷时,将向主要 CRA 发送一份备忘录
现场与质量控制专家沟通数据差异。质量控制专家
然后负责跟踪查询,直到在数据库中得到解决。审计报告包含在内
附录十一。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES L LOPRINZI其他文献
CHARLES L LOPRINZI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES L LOPRINZI', 18)}}的其他基金
Survivorship research established investigator award
生存研究设立研究者奖
- 批准号:
7826598 - 财政年份:2008
- 资助金额:
$ 10.47万 - 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
- 批准号:
7466151 - 财政年份:2008
- 资助金额:
$ 10.47万 - 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
- 批准号:
8078080 - 财政年份:2008
- 资助金额:
$ 10.47万 - 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
- 批准号:
8282597 - 财政年份:2008
- 资助金额:
$ 10.47万 - 项目类别:
Survivorship research established investigator award
生存研究设立研究者奖
- 批准号:
7629717 - 财政年份:2008
- 资助金额:
$ 10.47万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 10.47万 - 项目类别:
Fellowship Programs














{{item.name}}会员




